HWAY:NGS-Healthways Inc. (USD)

EQUITY | Others | Nasdaq Global Select

Last Closing

USD 27.5356

Change

-0.14 (-0.52)%

Market Cap

USD 0.89B

Volume

141.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Healthways Inc provides comprehensive total population health management solutions that are designed to help people improve their well-being, thereby improving their health and productivity and reducing their health-related costs.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
IBIT iShares Bitcoin Trust

+1.76 (+3.06%)

USD 54.00B
QQQM Invesco NASDAQ 100 ETF

-0.37 (-0.17%)

USD 38.66B
JEPQ JPMorgan Nasdaq Equity Premium..

-0.15 (-0.26%)

USD 20.93B
ACWI iShares MSCI ACWI ETF

-0.36 (-0.30%)

USD 19.52B
CGABL The Carlyle Group Inc. 4.625% ..

-0.16 (-0.84%)

USD 16.14B
NVDL GraniteShares 1.5x Long NVDA D..

-4.59 (-8.07%)

USD 5.86B
TBIL Rbb Fund Inc - Us Treasury 3 M..

N/A

USD 4.78B
TSLL Direxion Shares ETF Trust - Di..

-1.21 (-4.66%)

USD 4.68B
ETHA iShares Ethereum Trust ETF

+0.36 (+1.54%)

USD 3.75B
USCL iShares Climate Conscious & Tr..

-0.28 (-0.38%)

USD 2.37B

ETFs Containing HWAY

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.86% 81% B- 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.86% 81% B- 71% C-
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.89B 5% F 1% F

Key Financial Ratios

  Ratio vs. Industry/Classification (Others) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.